Ticker
RGNXCompany Name
REGENXBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 373.75M | 3.13 | $ 119.54M |
3/31/2025 | $ 313.24M | 2.93 | $ 106.73M |
12/31/2024 | $ 278M | 2.69 | $ 103.19M |
9/30/2024 | $ 313.4M | 3.05 | $ 102.72M |
6/30/2024 | $ 346.68M | 3.53 | $ 98.27M |
3/31/2024 | $ 395.42M | 3.59 | $ 110.18M |
12/31/2023 | $ 334.97M | 2.57 | $ 130.27M |
9/30/2023 | $ 365.84M | 2.87 | $ 127.35M |
6/30/2023 | $ 378.81M | 3.21 | $ 117.89M |
3/31/2023 | $ 389.2M | 3.46 | $ 112.33M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for REGENXBIO INC is calculated as follows: AssetsC [ $ 386.95M ] / LiabilitesC [ $ 63.61M ]
(=) Current Ratio [ 6.08 ]
Minimum
Dec 31, 2023
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.2K |
---|---|
min | 0 |
max | 6.79 |
average | 2.02 |
median | 1.62 |
std | 1.44 |